1. "Bone Marrow Transplant"
Formats
  1. Meeting Abstract (1488)
  2. Journal Article (1179)
  3. Review (70)
  4. Research Letter (46)
  5. Book Section (34)
  6. Guidelines (26)
  7. Editorial (23)
  8. Correspondence (17)
  9. Conference Paper (14)
  10. Book Whole (1)
  11. Miscellaneous (1)
Groups
  1. Bone Marrow Transplant (2899)
  2. Center for Hematologic Malignancies (2899)
  3. Department of Medicine (2899)
  4. Hematologic Malignancies, Division of (2776)
  5. Survivorship Research (1345)
  6. GSK Faculty (917)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Sean Devlin (457)
  4. Ann Jakubowski (456)
  5. Heather Landau (419)
  6. Gunjan Shah (418)

More People

Years
  1. 2025 (40)
  2. 2024 (169)
  3. 2023 (263)
  4. 2022 (201)
  5. 2021 (177)
  6. 2020 (208)

More Years

Publications
  1. Blood (840)
  2. Biology of Blood and Marrow Transplantation (516)
  3. Bone Marrow Transplantation (175)
  4. Journal of Clinical Oncology (125)
  5. Transplantation and Cellular Therapy (110)
  6. Blood Advances (88)

More Publications

Publishers
  1. American Society of Hematology (935)
  2. Elsevier Inc. (762)
  3. Nature Publishing Group (258)
  4. American Society of Clinical Oncology (127)
  5. Wiley Blackwell (65)
  6. Taylor & Francis Group (64)

More Publishers

Results (2899)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Rapid reduction of peripheral blasts in older patients with refractory acute myeloid leukemia (AML) using reinduction with single agent anti-CD45 targeted iodine ((131)I) apamistamab [lomab-B] radioimmunotherapy in the phase III SIERRA trial
    Meeting Abstract

    Tomlinson, B. K.; Reddy, V.; Berger, M. S.; Spross, J.; Lichtenstein, R.; Gyurkocza, B.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Inferior survival after microbiota injury: A multicenter alto-HCT study
    Meeting Abstract

    Peled, J. U.; Gomes, A. L. C.; Devlin, S. M.; Littmann, E. R.; Taur, Y.; Sung, A. D.; Weber, D.; Hashimoto, D.; Wright, R. J.; Amoretti, L.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Impact of geriatric vulnerability on outcomes of older patients in allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Lin, R. J.; Elko, T. A.; Devlin, S. M.; Flynn, J.; Jakubowski, A. A.; Shahrokni, A.; Dahi, P.; Perales, M. A.; Sanchez-Escamilla, M.; Tamari, R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • MSK-IMPACT Heme: Validation and clinical experience of a comprehensive molecular profiling platform for hematologic malignancies
    Meeting Abstract

    Ptashkin, R. N.; Benayed, R.; Ziegler, J.; Rema, A. B.; Sadowska, J.; Kiecka, I.; Ho, C.; Yao, J. J.; Moung, C.; Petrova-Drus, K.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Does donor kir-genotype impact outcome after unrelated hematopoietic stell cell transplantation for myelodysplastic syndromes or secondary acute myeloid leukemia?
    Meeting Abstract

    Schetelig, J.; Baldauf, H.; Koster, L.; Kuxhausen, M.; Heidenreich, F.; de Wreede, L. C.; Spellman, S.; Carolin, M.; Lange, V.; van Gelder, M.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • CMV outcomes and health care resource utilization in CMV-seropositive (R+) hematopoietic stem cell transplant (HCT) recipients managed with pre-emptive therapy (PET)
    Meeting Abstract

    Fang, J.; Zavras, P. D.; Su, Y.; Raval, A. D.; Tang, Y.; Perales, M. A.; Giralt, S.; Papanicolaou, G.
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • The SFGM-TC MDS score at day 180 is associated with post-transplant outcomes in patients with myelodysplastic syndrome who underwent CD34+ selected allogeneic stem cell transplant
    Meeting Abstract

    Alarcon, A.; Hilden, P. D.; Maloy, M.; Ruiz, J. D.; Sanchez-Escamilla, M.; Yañez, L.; Castillo, N.; Tamari, R.; Shaffer, B.; Castro-Malaspina, H.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Ruxolitinib in combination with corticosteroids for the treatment of steroid-refractory acute graft-vs-host disease: 6-month follow-up data from the phase 2 REACH1 trial
    Meeting Abstract

    Jagasia, M.; Ali, H.; Schroeder, M. A.; Shah, N. N.; Chen, Y. B.; Dawkins, F.; Arbushites, M.; Tian, C.; Perales, M. A.
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Letermovir in hematopoietic cell transplantation: Beyond the label
    Meeting Abstract

    Lin, A.; Maloy, M. A.; Bhatt, V.; DeRespiris, L.; Griffin, M.; Lau, C.; Proli, A. J.; Barker, J. N.; Shaffer, B. C.; Giralt, S. A.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • A phase II clinical trial of leuprolide for enhancement of immune reconstitution after ex vivo CD34+ cell-selected allogeneic HCT with TBI-based conditioning
    Meeting Abstract

    Cho, C.; Devlin, S. M.; Avecilla, S. T.; Castro-Malaspina, H.; Giralt, S. A.; Jakubowski, A. A.; Maloy, M.; Maslak, P.; O'Reilly, R. J.; Papadopoulos, E. B.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save